Japanese Cancer Association Meeting UICC International Session - What is Cost-effectiveness in Cancer Treatment?

Akaza, Hideyuki; Kawahara, Norie; Roh, Jae Kyung; Inoue, Hajime; Park, Eun-Cheol; Lee, Kwang-Sig; Kim, Sukyeong; Hayre, Jasdeep; Naidoo, Bhash; Wilkinson, Thomas; Fukuda, Takashi; Jang, Woo Ick; Nogimori, Masafumi

추천

검색

자료유형: 학술저널

저자정보: Akaza, Hideyuki (Department of Strategic Investigation on Comprehensive Cancer Network, Research Center for Advanced Science and Technology, University of Tokyo) Kawahara, Norie (Department of Strategic Investigation on Comprehensive Cancer Network, Research Center for Advanced Science and Technology, University of Tokyo) Roh, Jae Kyung (Yonsei Cancer Center, Yonsei University) Inoue, Hajime (Ministry of Health, Labour and Welfare) Park, Eun-Cheol (Department of Preventive Medicine, Yonsei University) Lee, Kwang-Sig (Department of Preventive Medicine, Yonsei University) Kim, Sukyeong (Research Department, Health Insurance Review and Assessment Service) Hayre, Jasdeep (National Institute for Health and Care Excellence [NICE]) Naidoo, Bhash (National Institute for Health and Care Excellence [NICE]) Wilkinson, Thomas (National Institute for Health and Care Excellence [NICE]) Fukuda, Takashi (National Institute of Public Health) Jang, Woo Ick (R&D Division) Nogimori, Masafumi (Astellas Pharma Inc.)

저널정보: 아시아태평양암예방학회 Asian Pacific journal of cancer prevention : APJCP Asian Pacific journal of cancer prevention : APJCP 제15권 제1호

발행연도: 2014.1

수록면: 3 - 10 (8page)

이용수

📌

연구주제

📖

연구배경

🔬

연구방법

🏆

연구결과

초록· 키워드

오류제보하기

The Japan National Committee for the Union for International Cancer Control (UICC) and UICC-Asia Regional Office (ARO) organized an international session as part of the official program of the 72nd Annual Meeting of the Japanese Cancer Association to discuss the topic "What is cost-effectiveness in cancer treatment?" Healthcare economics are an international concern and a key issue for the UICC. The presenters and participants discussed the question of how limited medical resources can be best used to support life, which is a question that applies to both developing and industrialized countries, given that cancer treatment is putting medical systems under increasing strain. The emergence of advanced yet hugely expensive drugs has prompted discussion on methodologies for Health Technology Assessment (HTA) that seek to quantify cost and effect. The session benefited from the participation of various stakeholders, including representatives of industry, government and academia and three speakers from the Republic of Korea, an Asian country where discussion on HTA methodologies is already advanced. In addition, the session was joined by a representative of National Institute for Health and Care Excellence (NICE) of the United Kingdom, which has pioneered the concept of cost-effectiveness in a medical context. The aim of the session was to advance and deepen understanding of the issue of cost-effectiveness as viewed from medical care systems in different regions.

#UICC-ARO #JCA meeting #cost-effectiveness #cancer treatment #guidelines

참고문헌 (0)

참고문헌 신청

참고문헌이 DBpia에서 서비스 중이라면, [참고문헌 신청]을 통해 등록해보세요

이 논문의 저자 정보

Akaza, Hideyuki

소속기관 Department of Strategic Investigation on Comprehensive Cancer Network, Research Center for Advanced